Cargando…
A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study
BACKGROUND: Vitamin K antagonists (VKA) are used as prophylaxis for thromboembolic events in patients with cardiovascular diseases. The most common VKA are warfarin and acenocoumarol. These drugs have a narrow therapeutic margin and high inter-individual response variability due to clinical and phar...
Autores principales: | Roco, Angela, Nieto, Elena, Suárez, Marcelo, Rojo, Mario, Bertoglia, Maria Paz, Verón, Gabriel, Tamayo, Francisca, Arredondo, Annabella, Cruz, Daniela, Muñoz, Jessica, Bravo, Gabriela, Salas, Patricio, Mejías, Fanny, Godoy, Gerald, Véliz, Paulo, Quiñones, Luis Abel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153463/ https://www.ncbi.nlm.nih.gov/pubmed/32327994 http://dx.doi.org/10.3389/fphar.2020.00325 |
Ejemplares similares
-
Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients
por: Rojo, Mario, et al.
Publicado: (2020) -
Anticoagulation Management With Coumarinic Drugs in Chilean
Patients
por: Nieto, Elena, et al.
Publicado: (2019) -
An Acenocoumarol Dosing Algorithm Using Clinical and Pharmacogenetic Data in Spanish Patients with Thromboembolic Disease
por: Borobia, Alberto M., et al.
Publicado: (2012) -
Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
por: Roco, Ángela, et al.
Publicado: (2014) -
Acenocoumarol’s pharmacokinetic: linear or not?
por: Kumar, Parveen, et al.
Publicado: (2019)